20+ Million Readerbase
PMC/PubMed Indexed Articles
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • CiteFactor
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • NSD - Norwegian Centre for Research Data
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Recommended Webinars & Conferences
Journal Flyer
Flyer image

Commentary - (2016) Volume 5, Issue 1

Gonadal Dysgenesis-with Special Emphasis on the Molecular Mechanisms of SRY Mutations in Disorders of Sex Development (DSD) Reulting in Female Sex Reversal in 46XY Males

Kulvinder Kochar Kaur*
Centre for Human Reproduction, Jalandhar, India
*Corresponding Author: Kulvinder Kochar Kaur, Centre for Human Reproduction, Jalandhar, India, Tel: 91-181-4613422 Email:

Abstract

SRY related high mobility group box (Sox) transcription factors have emerged in the animal kingdom to help cells maintain stemness, commit to a specific lineage, proliferate or die. Encoded by 20 genes in humans and mice they show a highly conserved high-mobility group boxdomain, which was originally identified in SRY, the sex determining region on the Y chromosome. This has derived from a high mobility group domain characterized of chromatin associated proteins. HMG (high mobility group) non histone chromosomal proteins include the AT hook, HMGN, and HMG domain families.

Keywords: chromosome, Testosterone, Protein, chromatin

Abbreviations

SRY: Sex determining Region in the Y chromosome; Sox: SRY related high mobilty boxtranscription factor; HMG: High Mobility Box; CGD: Complete Gonadal Dysgenesis; NLS: Nuclear Localization Signals; NPC: Nuclear Pore Complex; CaM: Calmodulin; AMH: Antimullerian Hormone; MIS: Mullerian Inhibiting Substance; T: Testosterone; HCG: Human Chorionic Gonadotrophin; PGD: Partial Gonadal Dysgenesis; WT1: Wilms Tumor-related gene; SF1/NR5A1: Steroidogenic Factor1/ Nuclear Receptor subfamily5group Amember1; ARX: Aristaless Related Homeobox; ATRX: α-Thallasemia, mental Retardation on the X; DMRT1: Double sex and Mab-3 Related Transcription factor 1; WNT4: Winglesstype mouse mammalian Tumour viral integration site; RSPO1: R-spondin 1; DAX1/NROB1: Dosage Sensitive Sex Reversal Adrenal hypoplasiaacute Regulatory Protein; DHH: Dessert Hedgehog; HHAT: O-Acetyl Methyl Transferase Hedgehog Acyl Trasferase; LoF: Loss of Functional variants; AA: Amino Acids; lncRNA: Long noncoding RNA; Xist: X Inactive Spectific Transcript; TES: Testis Enhancer Sequence; TESCO: Testis Enhancer Sequence Core element; TCON0025195&6: lnc RNAin SOX9 regulation; MHM: lnc RNA-2.2 kb sequence on chicken Z chromosome only in birds; FGF: Fibroblast Growth Factor; FGFR2: Fibroblast Growth Factor Receptor 2; PGD2: Prostaglandin D2; Pgds: Prostaglandind Synthase

Introduction

SRY related high mobility group box (Sox) transcription factors have emerged in the animal kingdom to help cells maintain stemness, commit to a specific lineage, proliferate or die. Encoded by 20 genes in humans and mice they show a highly conserved high-mobility group boxdomain, which was originally identified in SRY, the sex determining region on the Y chromosome. This has derived from a high mobility group domain characterized of chromatin associated proteins. HMG (high mobility group) non histone chromosomal proteins include the AT hook, HMGN, and HMG domain families [1].

Members of the Sox SRY (Sex determining region on the Y chromosome) related HMG box family of chromatin remodelling factors play important development roles. SRY plays a key role in mammalian sex determination as determined by the fact that 15% of all XY sex reversal individuals carry mutations in SRY [2-5]. It is located on the end of short arm of Y chromosome and encodes a protein of 204 amino acids. It is not a typical eukaryotic transcript unit but a single exon-containing gene without any intron. It is not a conservative gene as well in mammals SRY is expressed 7 weeks post fertilization in humans with a specific role in the nucleus, activating/coordinating the expression of genes such as related proteins Sox9 which also results in differentiation of presertoli cells to produce a testis and suppress genes favouring formation of female gonads [3-4,6,7]. In the case of XY sex reversal due to impaired action of SRY (Swyers syndrome), patients present with complete gonadal dysgenesis (CGD) or partial gonadal dysgenesis, which causes a defective phenotype, with female external genitalia and 1 in 2 presenting with a gonadal tumor. SRY is able to bind and bend specific DNA targets through its HMG box domains like other HMG proteins [3,8]. The majority of sex reversal mutations in SRY results in impaired DNA binding/ bending, but a number of which do not affect DNA binding map to one of SRY’s two independently functioning nuclear localization signals [NLS], which flank the HMGbox domain [3,4,9-11] of these C terminal β-NLS mediates nuclear import conventionally through the molecule importin β (Imp-β) (Figure 1) courtesy by Wilhelm D [12].

hereditary-genetics-molecular-pathways

Figure 1: A model of the most relevant molecular pathways in epithelial and stromal ectopic endometrial cells involved in the pathophysiology of endometriosis. *Major proinflammatory cytokines are produced in both peritoneal macrophages and endometriotic cells. **Altered peritoneal cell mediated immunity seen in endometiosis is related to inflammatory cytokine expression profile [1-9,12].

This facilitates transport through the nuclear pore complex(NPC) found embedded in nuclear envelope and release the nucleus on interaction with G protein monomeric binding proteins Ran activated G protein bound form [13,14]. The 2nd N terminal NLS, Calmodulin (CaM)-NLSbinds the Ca2+ binding protein CaM [15] Kaur, et al., showed a dual nuclear import and calmodulin dependent nuclear import importance in role of SRY in sex reversal after examining missense mutations in SRY CaM NLS from human XY sex reversal females [16,17].

Clinical feautures

Patients with pure or Complete Gonadal Dysgenesis (CGD) also known as Swyer’s Syndrome have a normal female phenotype, including uterus and fallopian tubes but they have streak gonads, mullerian structures due to insufficient AMH/MIS secretion and a complex absence of androgenisations. AMH/MIS is low and testosterone (T) response to human chorionic gonadotropin (HCG) stimulation is impaired. These patients are free of turners like malformations and attain normal height. Patients with partial gonadal dysgenesis (PGDordysgenetic gonads) may provide enough MIS to regress the uterus and sometimes sufficient for partial androgenisation. GD can result from mutations or deletions of testis promoting genes WT1 (wilms tumor-related gene), SF1 (steroidogenic factor 1), SR1, SOX9 (SRY related HMG box gene 9), DHH (desert hedgehog), ATRX (α-thallasemia, mental retardation on the X), ARX (Aristaless related homeobox, X linked), DMRT (double sex and mab3 related transcription factor 1). Also duplication of chromosomal loci containing antitestis genes e.g. WNT4 (wingless type mouse mammalian tumor virus integration site 4), RSPO1(R-spondin 1), DAX 1 also called NROB1 account for ~1% of the resolved cases [18] (dosage sensitive sex reversal adrenal hypoplasia acute regulatory protein) as reviewed by Wilhelm D and Mendonca BB [12,19]. Among these deletions or mutations of SF1 (NR5A1) appear to be the most common but still collectively account for <25% of cases. Associated clinical features maybe present reflecting additional functional roles for these genes. For example renal dysfunction occurs in patients with specific WT1 mutations (Denys Drash and Fraser’s syndrome). Primary adrenal failure occurs in some patients with SF1 mutations, DHH mutations cause GD associated with peripheral neuropathy and severe cartilage abnormalities (Campomelic dysplasia-a familial dwarf) are the predominant clinical feautures of SOX 9 mutations. Similarly recently 46XY DSD with CGD and chondrodysplasia has been found with a homozygous mutation (G287V) within coding sequence of O-acetyl transferase HHAT gene. HHAT gene codes for attachment of palmitolyl residues that are critical for multimerization and long term signaling of hedgehog secreted proteins [19]. Similarly recently 46XY DSD with CGD and chondrodysplasia has been found with a homozygous mutation (G287V) within coding sequenceof O-acetyl transferase HHAT gene. HHAT gene codes for attachment of palmitolyl residues that are critical for multimerization and long term signaling of hedgehog secreted proteins [19]. A family history of DSD or premature ovarianin sufficiency is important (eg. SF1/NR5A1). Intra-abdominal dysgenetic testis should be removed or prevent malignancy and oestrogens can be used to induce secondary sex reversal in 46XY individuals raised as females with absent (vanishing testes syndrome-(bilateral anorchia)- reflect regression of the test is during development. The etiology is unknown but the absence of mullerian structures indicates adequate secretion of AMH in utero and in most case and rogenisation of the external genitalia is either normal or slightly impaired e.g. small penis, hypospadias). These individuals can be of feredprosthesis and should receive androgen replacement in adolescence.

Role of noncoding RNA’S in male differentiation

In mammalians SRY is expressed for a short period in presertoli cells, which in this small time organizes for all other cell types where key roles for SRY in up regulation of Sox 9 which encodes a transcription factor belonging to the same SRY like HMG domain family [20]. Before SRY expression is up regulated in XY genital ridges Sox 9 is expressed at low levels both in developing testis and ovary [21] due to the binding and activation of SF1 to the testis enhancer sequence(TES)1. 4 Kb upstream of SOX 9 Transcription start site [22]. Subsequently SRY binds together to SF1 to a 1. 4 kb core element (TESCO) located within the TES resulting in up regulation of Sox 9 transcription within the testis whereas Sox9 becomes undetectable in ovary. After that Sox binds along with SF1 to TESCO to maintain its own expression.

• Sox 9 directly or indirectly up regulates FGF9, which then activates FGF signaling via FGFreceptor2 resulting in Sox 9 up regulation [23,24].

• Sox 9 directly stimulates expression of the prostaglandin D synthase (ptgds) gene leading to the production of prostaglandinD2 (PGD2) which leads to the translocation of SOX 9 protein from the cytoplasm into the nucleus and up regulation of its expression [25-27].

Although TESCO has been located in human genome ~13 kb upstream of the SOX 9 TSS [22], it is not known that if TESCO also mediates testis specific expression of SOX 9 in humans. Mapping of copy number variants in human patients with 46 XX and 46 XY female development identified a long distance regulatory region upstream of Sox 9 called Revsex which is likely to harbour an enhancer driving testis specific expression [28]. This region encodes two lncRNAs (TCONS00025195 and TCONS00025196 [29], which might be involved in up regulation of SOX9 expression in human testis (Figure 2).

hereditary-genetics-Putative-regulation

Figure 2: Putative regulation of Sox 9 expression by ncRNAs in mice: Sox 9 transcriptions is up regulated by the binding of SF1 and SRY&SRY or SF1&SOX9 to the enhancer region TESCO which is located 13 kb upstream of the Sox 9 transcription start site. The TESCO sequence is also present in humans but its relevance for testis specific Sox 9 expression is not clear. Rather the analysis of human patients with 46XX and 46XYDSD identified a second control region called Revsex located upstream of the Sox 9 Transcription start site. This region harbours two linc RNAs TCON 00025195, and TCON 00025196 which might be involved in regulating Sox 9 expression. In ADDITION Sox9 expression can be regulated by miR124 by binding to the 3’UTR of Sox 9mRNA. However it is unclear if this regulation occurs during gonadal differentiation. Finally Sox 9 likely funtions as a transcriptional activator of miRNAs such as miR 202 and miR140 [31].

In ovary miR 124 has been implicated in the down regulation of Sox9 [30] as reviewed by Rastetter, et al. [31]).

The Role of long non-coding RNA (lncRNA) in dosage compensation

In species with genetic sex determination such as XX female, XY male system in mammals and in the ZW female; ZZ male system in birds, males and females have a difference in se chromosome –linked gene dosage which has resulted in the evolution of dosage compensation mechanism in mammals which is realized by the inactivation of one of the X chromosomes through coating by an lncRNA called Xist (Xinactive specific transcript). The 19 kilobase long transcrip Xist is only transcrfibed from inactive X chromosome and coats hundreds of genes. Prior to inactivation an lncRNA that is antisense to Xist called Tsix is down regulated from one of the X chromosomes resulting in the Xist and inactivation of the X chromosome. On the active X, the maintenance expression of of Tsix prevents the full length Xist expression and X linked gene expression is unaffected reviewed by Moran [32]. This phenomenon on dosage compensation in mammals is clearly regulated by lncRNAs. But in other groups such as birds there is no inactivation of one sex chromosome of the homogenetic sex. However there is potential involvement of lncRNAs in dosage compensation in chicken as well. Chickens and other birds have a ZZ male, ZW female sex chromosome system. The Z linked transcription factor gene DMRT1, is thought to play a central role in avian sex determination by directing testis development in Z zebryos. Overexpression of DMRT1 induces the male specific genes HEMGN, SOX9 and AMH [33] (Figure 3).

hereditary-genetics-Potential-roles

Figure 3: Potential roles of the non-coding RNAs MHM in chicken. In ZZ male gonadal cells, Z linked MHM, a non-coding RNA, is methylated and transcriptionally silent. The neighboring DMRT1 gene is transcribed and is required for testis development, activating genes such as HEMOGEN and SOX9.miRNA 202-3pis also expressed in testis and may play a role in cord organisation. In ZW female cells MHM is hypo methylated and transcribed into long non coding RNAs that coast the Z adjacent to the DMRT1 locus. It may quench DMRT1 expression leading to less DMRT1 protein and allowing ovarian pathways genes to become active e.g. FOXL2, CYP19A1 and β-catenin [31].

MHM is a 2.2 kb sequence absent in other birds and MHM is located within a region of Z chromosome which corresponds to hyper acetylation of histone H4 which is associated with increased gene expression or second hypothesis MHM may regulate by in male cells ZZ MHM is hyper methylated and transcriptionally silent, whereas in female cells Zwit is hypo methylated and transcribed. Bing near DMRT1, it is suggested it may influence to dampen DMRT1 in female cells, by MHM lncRNA coating the chromosome adjacent to DMRT locus, inducing local chromatin conformational changes which may interfere by TF binding [34] -further reviewed by Rastetter, et al. [31].

Role of SRY mutations

Till now 80 mutations have been reported from a gene which encodes 204 aa’s, and although all cause either CGD/PGD, very little is understood how the mutations damage SRY function at the molecular level. Fan, et al. [35] reported a novel mutation in a case of Swyer syndrome which is a denovo mutation at nucleotide 224 of SRY coding region with guanine replaced by thymine and at protein level arginine is replaced at position 75 in aa of entire SRY region with methionine R75M in a 46 XY Karyotype with phenotypic female and associated dysgerminoma. They cloned a wild and mutated type SRY and showed mutated SRY greatly accumulated in cytoplasmas compared to wild type SRY which only localizes in nucleus [35].

To rule out other gene involvement trio base whole exomic sequencing studies using the DNA samples from proband and parents revealed no mutations especially in Desert Hedge Hog (DHH), NROB1 (DAX1), NR5A1/SF1, SOX9 which implicated denovo mutations in SRY is a single defect for sex reversal. On an estimation human genome, contains >100 genuine loss of functional (LoF) variants with >20 genes completely inactivated and on an approximation 5 common compete knockout genes in autosomes which may be associated with disorders or may be completely harmless [36,37]. They further used bioinformatics simulation analysis to predict about impact of analysis of R75 on SRY function and found R75 in wild type SRY can form a Hydrogen Bond with serine at 91 (S91) which makes the SRY protein fit well into the minor grove of DNA, while M75 in mutated SRY can’t do so. The authors reviewed the SRY mutations based on available references and analysed distribution pattern accordingly in density and continuity which may be useful for further study of structure and function and its relatedness with disorders of sex development.

They found a total of 80 mutations reported in 204 aa’s in full length of SRY from the gene bank available regarding human mutations [38]. 80 mutations occur/59 Codons, that show 1, 39599 mutations at an average. Among these 80 mutations, 66 concentratedin HMB domain (57-136) which take 82.59% (66/80) of total mutations. Of these HMG domain occurs in 46 codons, including 54 missense mutations (81.82%; 54/66), and 12 nonsense mutations (18.18%; 12/66), 18 double mutations (39.13%; 18/46), and 1 triple mutation (2. 1%; 1/46). Hence based on the continuity and density of mutations in HMG group –they divided it into 4 sub regions separated by 3 or more consecutive codons without mutations) region carries 22 codons (from 57-78) which include 7 as mutation free, 14 carrying 23 mutations because of 1 triple and 7 double mutations and a cluster of 3 codons from 74-76 that all show mutation without interruption. Their case of denovo R75 Moccurs in the middle of it. Second sub region spans 20 codons from 82-101 which contain a cluster of codon 10 codons from 87-96 with 14 mutations because of 4 double. Third sub region covering 13 codons 107-119 with 11 mutations including 5 mutations in a continuous 4 codons 107-110 because of 1 double mutation and 4th covers 12 codons-125-136 with 12 mutations. It is said 7 codons from 130-136 encode C terminus NLS, but observed mutation pattern suggested C terminal NLS may cover codons from 125-136.

Based on these mutation distribution and the experiments by authors they hypothesized that the N terminal NLS covers 22 amino acids from 57-78, while the C terminal NLS covers 12 aa’s from 125- 136. The epitope that determines the SRY-DNA interaction maybe strongly associated with 10 codons from 87-96 and 4 codons from 107- 110 in the HMG. The final confirmation they are still waiting the results of experiments in their lab oratory right now. Further they commented on the rare mutations occurring in first 56 codons-only 9 mutations of which all scattered in first 43 codons and nearest missense mutation at 2nd and 4th codon’s being understandable but the nearest missense mutation occurs in 3rd codon which causes a complete XY female sex reversal [39]. 5 mutations downstream to 137-163 with no mutations in last 40 codons from 164-204 (41/204), the observation could suggest some aa’s proximal downstream HMG still play a crucial role to keep SRY functional, with aa at distal downstream HMG being less functional. This gets further confusing as at least 40 aa’s contribute little to SRY function, why does the truncated SRY by nonsense mutations at codon 163 cause XY female sex reversal as reported [40]. The similar situation can be applied to the frame shift mutations at codon 158 and 159. It becomes interesting to know that the missense mutations of serine at codon 145 can diminish SRY-DNA interaction [41], means the aa’s outside the HMG domain can exert certain influences to SRY function by some way. HMG and occurrence of mutations and Swyer syndrome still suggests some crucial role in amino acids distal to HMG, but puzzle that can’t be solved is if last 40 aa’s contribute little to SRY function why truncated SRY with nonsense mutation in 163 Codon causes sex reversal and certain unanswered questions which they are still trying to solve in their laboratory.

References

  1. Lefebvre V, Durnitriu B, Perzo-Mendez A, Han Y, Pallavi B (2007) Control of cell fate and differentiation by Sry-related high mobility group (HMG) box (Sox) transcription factors. Int J Biochem Cell Biol 39: 2195-2214.
  2. VeitiaRA, Cortes SE, OtolengriC, PanhouxT, CotinoutC, et al. (2001)Testis determination in mammals: more questions than answers. Mol Cell Endocrinol179:3-16.
  3. Harley VR, ClarksonMJ, Argentaro A(2003) The molecular action and regulation of the testis determining factors SRY(sex determining regions on the Y chromosome)and Sox9(SRY-relatedhigh mobility group (HMG) box9. Endocr Rev 24:466-487.
  4. KnowerKC, KeyS, Harley VR(2003) Turning on the male SRY, SOX9 and sex determination in mammals. Cytogene Genome Res 101:185-198.
  5. Scherer G, HeidM, ErdelM, MeschedeD, HorstJ, et al. (1998) Three novel SRY mutations in XY gonadal dysgenesiscases without SRYmutatins. Cytogenet Cell Genet 80: 188-192.
  6. Swain A, Lovell-Badge R (1999) Mammalian sex determination: A molecular drama. Genes Dev13:755-767.
  7. GascaS, CanizaresJ, Barbara DSP, MajeariC, PaulaE, et al. (2002) Anuclear export signal within the high mobility group domain regulates the nucleocytoplasm translocation of Sox9 during sex determination. ProcNatlSocAcadSci USA. 99:11199-11204
  8. WernerMH, BranchiMF, GronenbornAM, Clote GM(1995) NMH spectroscopy analysis of the DNA conformation induced bythe human gestis determining factor SRY. Biochemistry 34:11998-120004.
  9. UeharaS, HarshiydaM, SatoK, NataM, FunatoT, et al. (2002) Complete XY gonadal dysgenesisand aspects of the SRY genotype and gonadal tumor formation. J Hum Genet 47:279-284.
  10. Michael CL, Harley VR(2002)Biochemical defects in eight SRY missense mutations causing XY gonadal dysgenesis. Mol Genet Metab17:217-225.
  11. Smith JM, Koopman PA(2004) The ins and outs of transcriptional control: nucleocytoplasmic shuttling in development and disease. Trends Genet 20:4-8.
  12. Wilhelm D, Palmer S, Koopman P (2007) Sex determination and gonadal development in mammals. PhysiolRev87:1-28.
  13. Harley VR, LayfieldS, MitchellCL, ForwoodJK, McdowellSG, et al. (2003) Defective importinbeta recognition and nuclearimportof the sex-determining factorSRY are associated with XY sex reversing mutations. ProcNatlAcaSci USA 100:7045-7050.
  14. CarwoodJK, HarleyVR, Jans DA(2001) The C terminal nuclear localization signalof the sex determining regionY (SRY)high mobility group domainmediates nuclear import through importin beta 1. J BiolChem 276: 16575-16582.
  15. KaurG, Delluc-LavieresV, PoonLK, ForwoodJK, JohnDJ, et al. (2010) Calmodulindependent nuclear import of HMG-box family nuclear factors: importance of the role of SRY in sex reversal. BiochemJ430:39-48.
  16. KaurG, Jans DA (2011) Dual nuclear importmechanisms of sex determining factor SRY: Intracellular Ca2+as a switch. FASEB J 25:665-675.
  17. KaurJ, Delluc-ClavieresA, PoonIK, ForwoodJK, GloverDJ, et al. (2010)Calmodulin-dependent nuclear import of HMG-box family nuclear facors :importance of the role of SRY in sex reversal. Biochem J 430:39-48.
  18. Domenice S, Correa RV, Costa EM, NishiMY, Vilain E, etal. (2004) Mutations in the SRY, DAX1, SF1and WNT4 genes in Brazilian sex-reversed patients. Braz J Med Biol Res 37:145-150.
  19. MendoncaBB, DomenceS, ArnholdIJ, Costa FM(2009) 46XYdisorsers ofsex development (DSD). ClinEndocrinol (Oxf) 70:173-187.
  20. Caller P, Calvel P, Matevossian A, Makrythnnsis P, Bernard P, et al. (2014) Loss of function mutations in the Palmitolyl-Transfrase HHAT leads to syndromic 46, XY disorder of sex development by Hedgehog protein Palmotoylation and signaling. PLOS 10: e1004340.
  21. Bowles K, Koopman P (2010) Sex determination in mammalian germ cells:extrinic versus intrinsic factors. Reproduction 139:943-958.
  22. Kobayashi A, Chang H, Chaboissier MC, Schedl A, Behringer RR(2005) Sox 9 in testis determination. Annalsthe New York Academy of Sciences1061:9-17.
  23. Sekido R, Lovell-Badge R (2008) Sex determination involves synergystic action of SRYand SF1on a specific SOX9 enhancer. Nature 453:930-934.
  24. Kim Y, Bingham N, SekidoR, Parker KL, Lovell-BadgeR, et al. (2007) Fibroblast growth factor receptor2regulates proliferation and sertoli differentiation during male sex determination. PNAS 104:16558-16563
  25. Bagheri-Fam S, Sim H, Bernard P, Jayakody I, Taketo MM, et al. (2005) Loss of Fgfr2leads to partial XY sex reversal. DevBiol314:71-73.
  26. Wilhelm D, Martinson F, Bradford S, Wilson MJ, Combs AN, et al. (2005) Sertoli cell dfferentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. DevBiol 287:111-124.
  27. Wilhelm D, Hiramatsu R, Mizusaki H, Widjaja L, Combes AN, et al. (2007) SOX9 regulates prostaglandin D synthase genetranscription in vivoto ensure testis development. JrBiolChem282:10553-10560.
  28. Moniot B, Declosenil F, Scherer G, Aritake K, Malki S, e t al. (2009)The PGD2 pathway, independently of FGF9, amplifiesSOX9 activityin sertoli cells during male sex differentiation. Development 136: 1813-1821.
  29. Benko S, Gordon CT, Mallet D, Sreenivasan R, Thauvin-Robinet C, et al. (2011) Disruption of a long distance regulatory region upstreamof SOX9 in isolated disorders of sex development. Jr Med Genet 48:825-830.
  30. Smyk M, Szafranski P, Startek M, Gambin A, Stankiewicz P (2013) Chromosome conformation capture-on chip analysis of long-range cis-interactions of the SOX9 promoter. Chromosome Res 21:781-788.
  31. Rastetter RH, Smith CA, Wilhelm D(2015) Therole of non-coding RNAs in male sex determination and differentiation. Reproduction 150:R93-R107.
  32. Moran VA, Perera RJ, Khalil AM(2012) Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 40:6391-6400.
  33. Lambeth LS, Raymond CS, Roeszler KN, Kuroiwa A, Nakata N, et al. (2014) Over-expression of DMRT1induces the male pathway in embryonic chicken gonads. DevBiol 389: 160-172
  34. RoeszlerN, Itman C, Sinclair AH, Smith CA(2012)The long non-coding RNA, MHM,plays a role in cicken embryonic development, including gonadogenesis. DevBiol366:317-326.
  35. Fan W, WengB, YinCX, HeSS, ZhangT, et al. (2016) A novelmissense mutation R75M in SRY coding region results in complete XY female sex reversal with bilateral ovarian dysgerminoma. J Assist Reprod Genet-in press.
  36. Mac Arthur DG, BalasubramaniamS, FrankishA, etal.(2012) A systematic survey of loss of function variants in human protein-coding genes. Science 335: 823-828.
  37. Lim ET, RaychaudharyS, Sanders SJ,Stevens C, Sabo A, etal. (2013) Rare complete knockout in humans: population distributions and significant role in autism spectrum disorders. Neuron 77:235-242.
  38. StensonPD, MortM, BallEV, ShawK, PhillipsA, et al. (2014) The human gene mutation database:building a comprehensive mutation repositoryforclinicaland molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133: 1-9.
  39. GimelliG, GimelliS, DimasiN, BicciardiR, Di Battista E, et al. (2007) Identification and molecular modelling of anovelfamilialmutation in the SRY gene implicated in the pure gonadal dysgenesis. Eur J Hum Genet 15: 76-80
  40. Tajima T, NakaeJ, ShinoharaN, Fujieda K(1994) Anovelmutation localized to the 3’non-HMG box region of the SRY region in 46, XY gonadal dysgenesis. HumMol Genet 3: 187-189.
  41. Sanchez-Moreno I, CantoP, MunhuiaP, de Leon MR, CisnerosB, et al. (2009) DNA binding activity studies and computational approach of mutant SRY in patients with 46, XY complete pure gonadal dysgenesis. Mol Cell Endocrinol 299: 212-218.
Citation: Kaur KK (2016) Gonadal Dysgenesis-with Special Emphasis on the Molecular Mechanisms of SRY Mutations in Disorders of Sex Development (DSD) Reulting in Female Sex Reversal in 46XY Males. Hereditary Genet 5:164.

Copyright: © 2016 Kaur KK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
bellicon